The systemic administration of opioids leads to potentially severe and undesirable and side
effects like sedation and drowsiness, vomiting and nausea, allergies, respiratory depression …

Lipid nanoparticles (liposomes) were first described in 1965, and several work have led to
development of important technical advances like triggered release liposomes and drug …

Several advancements have been made on the exact release of local anaesthetics
formulation and its efficiency at inducing motor and sensory block for an extended time has …

Nanoliposome has been introduced for nanoscale bilayer lipid vesicles. These are the nano
version of liposomes, having cell-specific targeting, required to achieve a desired drug …

Nanoliposomes are powerful drug delivery systems that have gained considerable attention
over the past decade. They are characterized by their biocompatibility, biodegradability, and …

In the last few decades, several formulations have evolved to realize better efficacy of
administered anesthesia. These innovative formulations have facilitated surgeons to perform …

From a clinical perspective, local anesthetics have rather widespread application in regional
blockade for surgery, postoperative analgesia, acute/chronic pain control, and even cancer …

Nanoparticles are bio-nanomaterials with specific physicochemical properties. Therapeutic
drugs are formulated in nanoparticles to enhance their pharmacokinetic and …

Liposome nanoparticles (LNPs), as a promising platform in drug delivery, combine the
advantages of both liposomes and inorganic/organic nanoparticles into a single system …

Nanoliposomes, or submicron bilayer phospholipid vesicles, are a novel tool to encapsulate
and deliver the active pharmaceutical ingredients. The listing of active substances for …